Esco Aster News & Events

Corporate Press Release

Esco Lifesciences Group and Its Affiliate, Esco Aster, Signs a Memorandum of Understanding with the Medical and Pharmaceutical Industry Technology Development Center (PITDC) Taiwan
SINGAPORE—13 March 2024 – In response to the next wave of advanced manufacturing as well as cGMP Standards in the cell therapy industry 4.0 and to consolidate Taiwan's competitive advantage in the bur ...
Read more

March 13, 2024

Esco Bioengineering (formerly Cesco Bioengineering) Goes Global as Esco Lifesciences Group's Founding Family Takes the Helm
SINGAPORE—27 October 2023— Esco Lifesciences Group’s (ELG) founding family is delighted to announce the acquisition of CESCO Bioengineering Co.Ltd., now rebranded as Esco Bioengineering (EscoBio). Thi ...
Read more

October 27, 2023

ISPE SG 2022: Here We Come!
Esco Aster with the Healthcare team is making a huge comeback during this year’s International Society for Pharmaceutical Engineering (ISPE) conference in Suntec Singapore Convention & Exhibition Cent ...
Read more

July 28, 2022

Esco Aster Making Its CellFarm-to-Table™ Certified Delicious with Its ISO 22000 Certification!
SINGAPORE, 16 June 2022 – Environmentally-friendly and sustainable meat production takes one big stride forward as Esco Aster clinches the ISO22000 food safety certification for its cultivated meat ma ...
Read more

June 16, 2022

Esco Aster and Saksham Scientific Instruments are Heading to PharmaLytica 2022
Esco Aster alongside with Saksham Scientific will gather to exhibit the proprietary CelCradle® Tide Motion bioreactor and the BioNOC™II macrocarriers in full view. The team is set on providing pharmac ...
Read more

May 23, 2022

Esco Aster Joins the World Vaccine Congress for the 6th Time
Singapore – On Apr. 18-21, Esco Aster, a vertically integrated contract research (CRO), contract development and manufacturing organization (CDMO), will exhibit onsite in the upcoming World Vaccine Co ...
Read more

April 04, 2022

High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor
Singapore – Esco Aster, a vertically-integrated contract research (CRO), contract development and manufacturing organization (CDMO), highlights the success of the recently published study in the int ...
Read more

March 31, 2022

Esco Aster Receives Food Processing License to Manufacture Cell-Based Cultivated Meat from Singapore Authorities
Singapore Food Agency (SFA) has approved Esco Aster for manufacturing cultured animal cells on the 28th of July, making the country a pioneer to manufacture cultured cells for commercial sale. ...
Read more

September 15, 2021

Macrocarrier-based 3D Tide Motion System for Mesenchymal Stromal Cell Expansion
SINGAPORE AND INDIA – Through a collaborative partnership between Stempeutics Research, India, and Esco Aster, Singapore, the first study to demonstrate the success of macrocarrier-based Tide Motion s ...
Read more

June 04, 2021

Esco Aster will be Presenting at BPI Digital Week
Esco Aster, a CDMO company headquartered in Singapore is partnering with BioProcess International Digital Week on December 7-10 to conduct a webinar on optimizing stem cell cultures. ...
Read more

December 02, 2020

ESCO ASTER ENTERS INTO MOU WITH AUSTRIA’S NUVONIS TECHNOLOGIES TO SUPPORT NOVEL VIRAL VACCINES IN ASIA

Esco Aster (Singapore) and Nuvonis Technologies (Austria) will sign a Memorandum of Understanding (MoU) for the early development and manufacturing of viral vaccines prevalent ...
Read more

October 04, 2018

ESCO ASTER AND WUHAN BIO-RAID BIOTECHNOLOGY ESTABLISH MEMORANDUM OF UNDERSTANDING FOR LENTIVIRAL VECTOR PLATFORM TO SUPPORT CAR-T PIPELINE IN CHINA

SINGAPORE AND CHINA, July 19, 2018 – Esco Aster, a contract development and manufacturing organization (CDMO) of Esco Group, today announced the launch of lentiviral vector pla ...
Read more

July 19, 2018

ESCO ASTER AND KONKUK UNIVERSITY COOPERATE ON PIG VACCINES IN ASIA

SINGAPORE AND KOREA, July 01, 2018 – Esco Aster, a leading independent contract development and manufacturing organization with its patent Tide Motion bioreactor technology, has signed a coll ...
Read more

July 01, 2018

AN EXCLUSIVE INTERVIEW WITH ESCO – FROM CLEANROOMS TO CONTAINMENT SYSTEMS

Esco Group is a Singapore-based life science company with a diversified portfolio and sales in over 100 countries. As a leading manufacturer of laborat ...
Read more

June 20, 2018

There's More to Canada!

Esco Aster, alongside with Esco VacciXcell will be back for the upcoming International Society for Cell Therapy (ISCT) 2018 at Palais Des Congres de Montreal, Canada from May 2 &nd ...
Read more

April 26, 2018

Esco Aster and Esco VacciXcell Made It West!

Esco Aster, a leading CDMO company in ASEAN that utilizes Esco VacciXcell’s Tide Motion technology, jump started the year right. The recently held World Vaccine Congress at Renaissance Hotel, ...
Read more

April 24, 2018

ESCO ASTER AND MAX PLANCK INSTITUTE COOPERATE ON RESEARCH OF HUMAN FLAVIVIRUS VACCINES

Esco Aster, a leading independent contract development and manufacturing organization underpinned by its patent Tide Motion bioreactor technology, has signed a cooperation agreement with the Max Pl ...
Read more

April 01, 2018

VISIT BY MINISTER FOR NATIONAL DEVELOPMENT AND SECOND MINISTER FOR FINANCE, LAWRENCE WONG, TO ESCO SINGAPORE

Esco Group, a renowned Singapore-based life science company, hosted a visit by the Minister for National Development and Second Minister for Finance, Mr Lawrence Wong on 31st January 201 ...
Read more

January 31, 2018

ESCO ASTER AND NATIONAL UNIVERSITY OF SINGAPORE ANNOUNCE A DEVELOPMENT OF 3D ORGANOIDS MINIATURE BIOREACTOR
Esco Aster, a leading independent contract development and manufacturing organization underpinned by its patent Tide Motion bioreactor technology, has signed a research collaboration agreement with De ...
Read more

January 29, 2018

ESCO ASTER AND NATIONAL UNIVERSITY OF SINGAPORE ANNOUNCE A DEVELOPMENT OF SINGLE-USE BIOREACTOR-BASED STEM CELLS
Esco Aster, a leading independent contract development and manufacturing organization underpinned by its patent Tide Motion bioreactor technology, has signed a technology development agreement with Na ...
Read more

January 08, 2018

ESCO ASTER AND BIOPROCESSING TECHNOLOGY INSTITUTE SIGN MEMORANDUM OF UNDERSTANDING TO INNOVATE ON CONTINUOUS BIOMANUFACTURING PLATFORM
Esco Aster, a leading independent contract development and manufacturing organization dedicated to Singapore’s R&D ecosystem, has signed a Memorandum of Understanding (MOU) with A*STAR&rsquo ...
Read more

December 18, 2017

ESCO ASTER AND INSTITUTE OF MOLECULAR CELL BIOLOGY ANNOUNCE A COLLABORATION TO ACCELERATE PRECLINICAL DEVELOPMENT OF A HAND FOOT AND MOUTH VACCINE
Esco Aster, a leading independent contract development and manufacturing organization dedicated to the Singapore's R&D ecosystem, has signed a research collaboration agreement with A*STAR's Institute ...
Read more

December 07, 2017

ESCO ASTER UNVEILED NEW AND IMPROVE TIDECELL® AT A*STAR SCIENTIFIC BIOPOLIS ROADSHOW
Esco Aster, a leading independent contract development and manufacturing organization dedicated to the Singapore's R&D ecosystem, has unveiled its new and improved TideCell®, CelCradle™ and ...
Read more

November 30, 2017

Imagine the Possibilities: From Science to Society
Esco Aster is strengthening its core in bioprocessing for being one of the exhibitors of the upcoming Research Support Center Scientific Roadshow on November 14, 2017, starting from 9:30 am to 3:30 pm ...
Read more

November 08, 2017

Introducing Esco Aster Contract Development and Manufacturing Organization (CDMO)
A CDMO or Contract Development and Manufacturing Organization is a contractual company that provides services like drug development and drug manufacturing in the healthcare industry. CDMO services run ...
Read more

June 15, 2017

Technology & Solution News

The Health Quarters: Esco Healthcare Quarterly Newsletter (Issue 5, July 2022)
Esco Healthcare unveils the 5th issue of its quarterly newsletter, The Health Quarters (The HQ). Emphasis is given on how much have changed in biopharmaceutical processing, especially with the hit of ...
Read more

July 05, 2022

The Health Quarters: Strengthening cGMP compliance for Pharmaceutical Drugs and Biologics Manufacturing (Issue 4, March 2022)
The fourth (4th) issue release of The Health Quarters (HQ) newsletter focuses and touches on a wide range of technologies and solutions for the manufacture of pharmaceutical drugs and biological produ ...
Read more

March 04, 2022

Cultivated Meat – The Future of Food
Due to our growing population, unsurprisingly comes more demand in food production. Meeting this urgency has become a significant challenge to the agricultural industry, ...
Read more

January 06, 2022

The Health Quarters: Year In Review: Healthcare’s Year-End Issue (Issue 3 | December 2021)
Indeed, 2021 has enriched the healthcare sector with discoveries and innovations that have improved and reshaped people’s way of living. As we head towards the end of the year, Esco Healthcare once ag ...
Read more

December 21, 2021

The Health Quarters: Onward Vaccine Manufacturing Technology And Solutions | Esco Healthcare Quarterly Newsletter
Public health measures are interventions used to mitigate the spread of diseases during outbreaks and pandemics. Hence, vaccine development is among the top priorities to help reduce the burden of inf ...
Read more

August 02, 2021

The Health Quarters: Esco Healthcare Quarterly Newsletter (Issue 1, May 2021)

Esco Healthcare unveils the first issue of its quarterly newsletter, The Health Quarters (The HQ), featuring its esteemed project highlight, informative behind-the-product technological princ ...
Read more

May 01, 2021

Earth Day 2021: Food Services from Lab to Table
Esco Aster joins the #RestoreOurEarth campaign for Earth Day 2021 as it emphasizes the need for consumers to find alternative sustainable diet options. As one of the pillars of the campaign, Food and ...
Read more

April 22, 2021

ISCT 2020 Paris Virtual Event Appreciation

Esco Aster was recently live at the ISCT 2020 Paris Virtual event from May 28 to May 29. We would like tot thank all for viisting our virtual booth and viewing our poster on "Large Scale 3D Biore ...
Read more

June 03, 2020

Mesenchymal Stromal Cells as a Potential Treatment for COVID-19

The COVID-19 pandemic ravages healthcare systems globally, giving impetus for research institutes around the world to explore a widespread of clinical solutions to aid recovery ...
Read more

May 27, 2020

Esco Aster Gathers Key Collaborators to Advance Mobile Diagnostic Labs Aster Xpress™ in Singapore and Globally

SINGAPORE - The recently launched Esco Aster Mobile Diagnostic Lab Aster Xpress™ is the first and till date a commercially available, turnkey solution, vertically integrated wi ...
Read more

May 18, 2020

Esco Aster Launches Modular Isolation Rooms for COVID-19

Esco was the first company in 1978 to build isolation rooms in Singapore and the whole ASEAN region; with its collective 42 years of experience, it is proud to launch the Read more

April 23, 2020

COVID-19 Test Timings: What is the recommended test and when should it be performed?

The key message “Test, Test, Test” delivered by the WHO Director-General, Dr. Tedros Ghebreyesus, last Mar. 16 was directed for all countries; testing every suspect ...
Read more

April 17, 2020

Esco Aster Launches Phase 1 COVID-19 Swab Booths of Trace, Test, and Treat Platform

Esco Aster launches phase 1 of its end to end Trace, Test, and Treat Platform starting with COVID-19 swab booths. ...
Read more

April 15, 2020

Esco Aster End to End Platform, DX, Therapeutics and Vaccines, Self-Sufficiency in CoVID-19 Pandemic

As various countries around the world are working in unity to control the CoVID outbreak and flatten the disease curve, Esco Aster has been working untiringly since patient zer ...
Read more

March 23, 2020

Kết quả thử nghiệm công nghệ TideMotion bởi Esco Aster bản tiếng Việt
(Esco Aster Releases Vietnamese-Translated Tide Motion Data to the Public)

Esco Aster không ngừng vươn tầm nhìn và nỗ lực với sứ mệnh tạo ra các công nghệ cho phép tự sản xuất vắc-xin, thuốc sinh học tương tự (biosimilar) , liệu pháp gen, liệu pháp c ...
Read more

December 11, 2019

ARE YOUR COSMETICS DOING ENOUGH?

With millions of aging baby boomers, the hottest trend in the skin care industry is cosmeceuticals. Cosmeceuticals are topical cosmetic-pharmaceutical hybrids containi ...
Read more

December 04, 2019

Esco Aster: At The Forefront of Cell and Gene Therapies

SINGAPORE - Esco Aster, the Contract Development and Manufacturing Organization (CDMO) subsidiary of Esco Group of Companies, is poised for growth as we continue the outfitting ...
Read more

November 29, 2019

Esco Aster launches our latest CelCradle X in Singapore Stem Cell Society Symposium (SCSS)together with International Society of Cell & Gene Therapy (ISCT)

SINGAPORE – Esco Aster, the contract development and manufacturing organization (CDMO) subsidiary of Esco Group of Companies, completed the re-engineering of a Tide Motion ...
Read more

November 13, 2019

BIOACTIVE PEPTIDES: Applications and Our Solutions!

Biopeptides are organic, isolated small fragments formed by amino acids joined by amides or peptide bonds and derived mainly from food proteins like hydrolysates, shellfish, fu ...
Read more

November 04, 2019

Esco Aster’s Aseptic and/or Potent Processing with cGMP Isolators

SINGAPORE – Esco Aster, the cGMP contract development and manufacturing organization (CDMO) subsidiary of Esco Group of companies, continues to provide turnkey manufacturing so ...
Read more

October 14, 2019

ESCO ASTER AND A*STAR’S BIOPROCESSING TECHNOLOGY INSTITUTE TO ADVANCE BIOPROCESSING TECHNOLOGIES FOR CELL AND GENE THERAPIES

SINGAPORE – Esco Aster, a contract development and manufacturing organisation (CDMO) of Esco Group, today announced the official opening of the BTI–ESCO ASTER Centre of Excelle ...
Read more

January 24, 2019

LAUNCH OF TECHNOLOGY WORKSHOP TO SUPPORT INDUSTRY DRIVE TOWARDS BIOPROCESSING

SINGAPORE – Esco Aster, a contract development and manufacturing organisation (CDMO) and leader in bioprocessing technology, announced today the launch of Technology Workshop “ ...
Read more

January 15, 2019

ESCO ASTER JOINS BIO-PROCESS SYSTEM ALLIANCE

Esco Aster Singapore is now a member of the international Bio-Process System Alliance (BPSA), an industry group promoting the implementation of single-use systems for biotherap ...
Read more

October 24, 2018

Events

No more events.